These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10895161)

  • 1. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Nilsson T; Sjöblom A; Masucci MG; Rymo L
    Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ; Jacquemin MG; Farrell PJ
    Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced signal transduction through glucocorticoid receptor in Burkitt's lymphoma cell lines.
    Sinclair AJ; Jacquemin MG; Brooks L; Shanahan F; Brimmell M; Rowe M; Farrell PJ
    Virology; 1994 Mar; 199(2):339-53. PubMed ID: 8122366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    Brooks L; Yao QY; Rickinson AB; Young LS
    J Virol; 1992 May; 66(5):2689-97. PubMed ID: 1313894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
    Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.
    Kis LL; Takahara M; Nagy N; Klein G; Klein E
    Immunol Lett; 2006 Apr; 104(1-2):83-8. PubMed ID: 16386314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene.
    Tsai CN; Liu ST; Chang YS
    DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.
    Krauer KG; Belzer DK; Liaskou D; Buck M; Cross S; Honjo T; Sculley T
    Virology; 1998 Dec; 252(2):418-30. PubMed ID: 9878621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Epstein-Barr virus recombinants with deletions of the BamHI C promoter.
    Swaminathan S
    Virology; 1996 Mar; 217(2):532-41. PubMed ID: 8610445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.